DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20212630

Gradings of periodontitis in relation with systemic disease

Abdulhameed G. Albeshr, Yazeed A. Alhabdan, Raef Mohamad Aljasem, Maha Assad Munshi, Ahmed Mohammadhassan Bagasi, Mohammed Yaseer Al Khars, Naif Mayouf Alrasheedi, Mohammed Bandar Alodiani, Mohammed Abdulrahman Alnefaie, Wesam Yousef Alibrahim, Reem Mohammed Alharbi, Hadeel Fahad Aljuaid

Abstract


With the increasing prevalence rates of periodontitis cases, it has a great impact on human health, especially elderly patients. It constitutes a major health problem that can cause significant burdens. Infections are the main pathology that have been previously reported among studies in the literature because it has a strong correlation. There are common mechanisms that can cause systemic diseases: induction of systemic inflammation, inflammatory markers, the release of toxins, and translocation into other organs through the bloodstream. Proving the correlation between the potential presence of the involved pathogen and systemic diseases might be a significant key factor in predicting these systemic events. In addition, it will assist to have proper management in early intervention. The aim of the study was to provide more insight into the effect of correlation between periodontitis and other systemic diseases according to studies in the literature. Multiple organisms that can cause periodontitis have been significantly correlated with the development of many systemic diseases, such as atherosclerosis, coronary artery disease (CAD), pneumonia, respiratory tract infections, oral and colorectal cancers, diabetes and Alzheimer’s disease. Moreover, Porphyromonas gingivalis has been commonly reported with the variously discussed systemic diseases which should draw more attention towards the proper management and prevent this organism and other microbes within the literature to enhance the outcomes.


Keywords


Periodontitis, Dentistry, Complications, Systemic, Inflammation

Full Text:

PDF

References


Richards D. Oral diseases affect some 3.9 billion people. Evid Based Dent. 2013;14(2):35.

CDC researchers find close to half of American adults have periodontitis. J Can Dent Assoc. 2012;78:136.

Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25(2):134-44.

Whitmore SE, Lamont RJ. Oral bacteria and cancer. PLoS Pathog. 2014;10(3):1003933.

Yeo BK, Lim LP, Paquette DW, Williams RC. Periodontal disease- the emergence of a risk for systemic conditions: pre-term low birth weight. Ann Acad Med Singap. 2005;34(1):111-6.

Kim J, Amar S. Periodontal disease and systemic conditions: a bidirectional relationship. Odontology. 2006;94(1):10-21.

Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J. 2007;154(5):830-7.

Pussinen PJ, Jousilahti P, Alfthan G, Palosuo T, Asikainen S, Salomaa V. Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler Thromb Vasc Biol. 2003;23(7):1250-4.

Figuero E, Sanchez BM, Cuesta FS, Tejerina JM, Castro JA, Gutierrez JM, et al. Detection of periodontal bacteria in atheromatous plaque by nested polymerase chain reaction. J Periodontol. 2011;82(10):1469-77.

Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000;71(10):1554-60.

Nakano K, Inaba H, Nomura R, Nemoto H, Takeda M, Yoshioka H, et al. Detection of cariogenic Streptococcus mutans in extirpated heart valve and atheromatous plaque specimens. J Clin Microbiol. 2006;44(9):3313-7.

Chukkapalli SS, Rivera MF, Velsko IM, Lee JY, Chen H, Zheng D, et al. Invasion of oral and aortic tissues by oral spirochete Treponema denticola in ApoE(-/-) mice causally links periodontal disease and atherosclerosis. Infect Immun. 2014;82(5):1959-67.

Velsko IM, Chukkapalli SS, Rivera MF, Lee JY, Chen H, Zheng D, et al. Active invasion of oral and aortic tissues by Porphyromonas gingivalis in mice causally links periodontitis and atherosclerosis. PLoS One. 2014;9(5):97811.

Slocum C, Coats SR, Hua N, Kramer C, Papadopoulos G, Weinberg EO, et al. Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation. PLoS Pathog. 2014;10(7):1004215.

Herzberg MC, Meyer MW. Effects of oral flora on platelets: possible consequences in cardiovascular disease. J Periodontol. 1996;67(10):1138-42.

Sharma A, Novak EK, Sojar HT, Swank RT, Kuramitsu HK, Genco RJ. Porphyromonas gingivalis platelet aggregation activity: outer membrane vesicles are potent activators of murine platelets. Oral Microbiol Immunol. 2000;15(6):393-6.

Hajishengallis G, Wang M, Bagby GJ, Nelson S. Importance of TLR2 in early innate immune response to acute pulmonary infection with Porphyromonas gingivalis in mice. J Immunol. 2008;181(6):4141-9.

Sonti R, Fleury C. Fusobacterium necrophorum presenting as isolated lung nodules. Respir Med Case Rep. 2015;15:80-2.

Williams MD, Kerber CA, Tergin HF. Unusual presentation of Lemierre's syndrome due to Fusobacterium nucleatum. J Clin Microbiol. 2003;41(7):3445-8.

Heo SM, Sung RS, Scannapieco FA, Haase EM. Genetic relationships between Candida albicans strains isolated from dental plaque, trachea, and bronchoalveolar lavage fluid from mechanically ventilated intensive care unit patients. J Oral Microbiol. 2011;3.

Filho IS, Oliveira TF, Cruz SS, Passos SS, Trindade SC, Oliveira MT, et al. Influence of periodontitis in the development of nosocomial pneumonia: a case control study. J Periodontol. 2014;85(5):82-90.

Porto AN, Borges AH, Rocatto G, Matos FZ, Borba AM, Pedro FL, et al. Periodontal and Microbiological Profile of Intensive Care Unit Inpatients. J Contemp Dent Pract. 2016;17(10):807-14.

Centor RM, Atkinson TP, Ratliff AE, Xiao L, Crabb DM, Estrada CA, et al. The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med. 2015;162(4):241-7.

Roulis E, Polkinghorne A, Timms P. Chlamydia pneumoniae: modern insights into an ancient pathogen. Trends Microbiol. 2013;21(3):120-8.

Mantyla P, Stenman M, Paldanius M, Saikku P, Sorsa T, Meurman JH. Chlamydia pneumoniae together with collagenase-2 (MMP-8) in periodontal lesions. Oral Dis. 2004;10(1):32-5.

Filardo S, Pietro M, Schiavoni G, Minniti G, Ortolani E, Romano S, et al. Chlamydia pneumoniae Clinical Isolate from Gingival Crevicular Fluid: A Potential Atherogenic Strain. Front Cell Infect Microbiol. 2015;5:86.

Yamaguchi H, Oshio I, Osaki T, Kurata S, Yamamoto Y, Kamiya S. Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood. Int J Exp Pathol. 2006;87(2):121-9.

Campbell LA, Rosenfeld ME. Infection and Atherosclerosis Development. Arch Med Res. 2015;46(5):339-50.

Fukugaiti MH, Ignacio A, Fernandes MR, Ribeiro JU, Nakano V, Avila CMJ. High occurrence of Fusobacterium nucleatum and Clostridium difficile in the intestinal microbiota of colorectal carcinoma patients. Braz J Microbiol. 2015;46(4):1135-40.

Warren RL, Freeman DJ, Pleasance S, Watson P, Moore RA, Cochrane K, Allen VE, et al. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome. 2013;1(1):16.

Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207-15.

Yu YN, Yu TC, Zhao HJ, Sun TT, Chen HM, Chen HY, et al. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Oncotarget. 2015;6(31):32013-26.

Thieu H, Bach DB, Nam NH, Reda A, Duc NT, Alshareef A, Nguyen JG, et al. Antibiotic resistance of Helicobacter pylori infection in a children's hospital in Vietnam: prevalence and associated factors. Minerva Med. 2020;111(5):498-501.

Michaud DS, Fu Z, Shi J, Chung M. Periodontal Disease, Tooth Loss, and Cancer Risk. Epidemiol Rev. 2017;39(1):49-58.

Yao QW, Zhou DS, Peng HJ, Ji P, Liu DS. Association of periodontal disease with oral cancer: a meta-analysis. Tumour Biol. 2014;35(7):7073-7.

Wen BW, Tsai CS, Lin CL, Chang YJ, Lee CF, Hsu CH, et al. Cancer risk among gingivitis and periodontitis patients: a nationwide cohort study. QJM. 2014;107(4):283-90.

Inaba H, Sugita H, Kuboniwa M, Iwai S, Hamada M, Noda T, et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell Microbiol. 2014;16(1):131-45.

Gao S, Li S, Ma Z, Liang S, Shan T, Zhang M, et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect Agent Cancer. 2016;11:3.

Gallimidi A, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6(26):22613-23.

Ha NH, Woo BH, Kim DJ, Ha ES, Choi JI, Kim SJ, et al. Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties. Tumour Biol. 2015;36(12):9947-60.

Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. J Periodontol. 2003;74(1):97-102.

Yki JH, Sammalkorpi K, Koivisto VA, Nikkila EA. Severity, duration, and mechanisms of insulin resistance during acute infections. J Clin Endocrinol Metab. 1989;69(2):317-23.

Fernandez RJM, Lopez BA, Vendrell J, Ferri MJ, Recasens M, Ricart W. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care. 2006;29(5):1058-64.

Teeuw WJ, Gerdes VE, Loos BG. Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care. 2010;33(2):421-7.

Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol 2000. 2007;44:127-53.

Xavier AC, Silva IN, Costa Fde O, Correa DS. Periodontal status in children and adolescents with type 1 diabetes mellitus. Arq Bras Endocrinol Metabol. 2009;53(3):348-54.

Kothari M, Spin NR, Nielsen JF. Comprehensive oral-health assessment of individuals with acquired brain-injury in neuro-rehabilitation setting. Brain Inj. 2016;30(9):1103-8.

Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21(3):383-421.

Gaur S, Agnihotri R. Alzheimer's disease and chronic periodontitis: is there an association?. Geriatr Gerontol Int. 2015;15(4):391-404.

Bui FQ, Almeida SCLC, Huynh B, Trinh A, Liu J, Woodward J, et al. Association between periodontal pathogens and systemic disease. Biomed J. 2019;42(1):27-35.